Patents by Inventor Yongxia GUAN

Yongxia GUAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • APPLICATION OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN PREPARATION OF DRUGS FOR TREATING NEURITIS
    Publication number: 20250017994
    Abstract: A traditional Chinese medicine composition for treating neuritis. The traditional Chinese medicine composition is prepared mainly from Notopterygii Rhizoma et Radix, Angelicae Pubescentis Radix, Poria, Saposhnikoviae Radix, Schizonepetae Herba, Chuanxiong Rhizoma, Platycodonis Radix, Bupleuri Radix, Peucedani Radix, Aurantii Fructus, and Glycyrrhizae Radix et Rhizoma. The traditional Chinese medicine composition can significantly relieve facial paralysis, movement disorders, and other related symptoms of facial neuritis in a rat, remarkably improve expression of VEGFb, VEGFR1, and VEGFR2 proteins in postoperative side facial nerves of the rat, and promote recovery and regeneration of damaged rear axons.
    Type: Application
    Filed: December 1, 2022
    Publication date: January 16, 2025
    Applicant: Shandong New Time Pharmaceutical Co., Ltd.
    Inventors: Guimin Zhang, Chenglei Sun, Jingchun Yao, Yongxia Guan, Qingwen Ma
  • Use of icaritin in preparing medicament for preventing or treating hematocytopenia
    Patent number: 10799521
    Abstract: The present application relates to a method of icaritin in preventing or treating hematocytopenia. Particularly, icaritin may be used to prevent or treat bone marrow suppression caused by chemotherapeutic drugs, and may also be used to prevent or treat thrombocytopenia, for example, immune thrombocytopenia.
    Type: Grant
    Filed: December 23, 2019
    Date of Patent: October 13, 2020
    Assignee: LUNAN PHARMACEUTICAL GROUP CORPORATION
    Inventors: Zhiquan Zhao, Jingchun Yao, Xin Li, Yongxia Guan, Guangyan Li
  • USE OF ICARITIN IN PREPARING MEDICAMENT FOR PREVENTING OR TREATING HEMATOCYTOPENIA
    Publication number: 20200147115
    Abstract: The present application relates to a method of icaritin in preventing or treating hematocytopenia. Particularly, icaritin may be used to prevent or treat bone marrow suppression caused by chemotherapeutic drugs, and may also be used to prevent or treat thrombocytopenia, for example, immune thrombocytopenia.
    Type: Application
    Filed: December 23, 2019
    Publication date: May 14, 2020
    Inventors: Zhiquan ZHAO, Jingchun YAO, Xin LI, Yongxia GUAN, Guangyan LI
  • Use of icaritin in preparing medicament for preventing or treating hematocytopenia
    Patent number: 10555962
    Abstract: The present application relates to use of icaritin in preparing a medicament for preventing or treating hematocytopenia. Particularly, icaritin may be used to prevent or treat bone marrow suppression caused by chemotherapeutic drugs, and may also be used to prevent or treat thrombocytopenia, for example, immune thrombocytopenia.
    Type: Grant
    Filed: October 20, 2014
    Date of Patent: February 11, 2020
    Assignee: Lunan Pharmaceutical Group Corporation
    Inventors: Zhiquan Zhao, Jingchun Yao, Xin Li, Yongxia Guan, Guangyan Li
  • USE OF ICARITIN IN PREPARING MEDICAMENT FOR PREVENTING OR TREATING HEMATOCYTOPENIA
    Publication number: 20160250243
    Abstract: The present application relates to use of icaritin in preparing a medicament for preventing or treating hematocytopenia. Particularly, icaritin may be used to prevent or treat bone marrow suppression caused by chemotherapeutic drugs, and may also be used to prevent or treat thrombocytopenia, for example, immune thrombocytopenia.
    Type: Application
    Filed: October 20, 2014
    Publication date: September 1, 2016
    Applicant: Lunan Pharmaceutical Group Corporation
    Inventors: Zhiquan ZHAO, Jingchun YAO, Xin LI, Yongxia GUAN, Guangyan LI